Kanbi  Pharma  Teknoloji  Limite
1428243-26-8
CAS 1428243-26-8 | (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester
CAS 1428243-26-8 | (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester

1428243-26-8

Non pwodwi: (3R, 4S) -3- (2-Bromoacetyl) -4-etil-1-pyrolidinecarboxylic asid phenylmethyl ester
Nimewo CAS: 1428243-26-8
Fòmil molekilè: C16H20BrNO3
Pwa molekilè: 354.24
Nimewo EINECS:
MDL No.:MFCD30802183

Voye rechèch
Dekri teren

Pwopriyete:
Pwen bouyi: 453.1 ± 45.0 degre C (Prevwa)
Dansite: 1.361 ± 0.06 g/cm3 (Prevwa)
Koyefisyan asidite (pKa): {{0}}.91 ± 0.60 (Predi)

 

Sinonim:

(3R,4S)-3-(2-Bromoacetil)-4-etil-1-pirrolidinkarboxilik asid fenilmetil ester;

entèmedyè ofabt 594;

(3R,4S)-benzyl3-(2-bromoacetil)-4-etilpirrolidin-1-karboxylate;Benzyl(3R,4S)-3-(2- bromoacetyl)-4-etilpirrolidin-1- carboxylate;

Upadacitinib entèmedyè5;

1-Pyrrolidinecarboxylicacid,3-(2-bromoacetyl)-4-etil-,phenylmethylester,(3R,4S)-;

Upadacitinib entèmedyè;

(3R,4S)-3-(2-Bromasetil)-4-etilpirrolidin-1-karboksilat;

Baj popilè: 1428243-26-8, Lachin 1428243-26-8 manifaktirè, founisè

Inquiry
goTop

(0/10)

clearall